Publish in this journal
Journal Information
Vol. 55. Issue 9.
Pages 451-452 (September 2019)
Vol. 55. Issue 9.
Pages 451-452 (September 2019)
Editorial
DOI: 10.1016/j.arbr.2019.01.012
Full text access
Differential Factors in Fume Fever
Fiebre por humos, qué debemos distinguir
Visits
...
Javier de Miguel Díez
Corresponding author
javier.miguel@salud.madrid.org

Corresponding author.
, Alicia Cerezo Lajas, Luis Puente Maestu
Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

The effects of occupational exposure to toxic substances have been recognized for many years. One of the occupational diseases that affects the respiratory system is fume fever. It occurs, as the name suggests, after inhalation of harmful substances and is caused by a non-specific inflammatory response, rather than a hypersensitivity reaction. The principal entities of this type are metal fume fever (MFF) and polymer fume fever (PFF).1–3 Although these are familiar processes, they are often overlooked in clinical practice,4 hence the interest in making periodic updates of this entity.

MFF occurs as a result of occupational exposure to metal oxide fumes which are produced in certain situations where metals are heated above their melting point, during welding, for example.5 Most cases occur after exposure to zinc oxide, but they have also been described in association with other metals (copper, iron, aluminum, mercury, cadmium, magnesium, manganese, antimony, and tin).1,2

PFF is caused by inhaling products derived from the thermal decomposition of certain fluoropolymers.6 One of the common is polytetrafluoroethylene, used for its lubricating properties, thermal stability and electrical insulation. It is harmless except if heated above 300°C, at which stage it will begin to release degradation products.2

The pathophysiology of these processes is not clear, although they seem to be caused by a direct toxic effect. Exposure to metal fumes causes neutrophilic alveolitis and the release of cytokines by the lung cells, including tumor necrosis factor-alpha, interleukin (IL)-1, IL-6, and IL-8.5,7,8

MFF can occur in any individual, and a particular sensitization to metal fumes is not a prerequisite. Exposed workers develop tachyphylaxis, that is to say, a rapid adaptation after repeated exposure with reduced symptoms which recur after several days of absence of exposure (“Monday morning fever”). A possible cause of this adaptation is the synthesis of metallothioneins, induced by exposure to metals. In contrast, workers affected by PFF do not develop tachyphylaxis. In this case, there is a strong relationship between the onset of symptoms and smoking.1,2,9

In clinical terms, both MFF and PFF manifest as a self-limiting febrile syndrome, similar to influenza. Onset is usually rapid, occurring between 3 and 12h after exposure and resolution is spontaneous, usually within 24–48h.1,2

In the case of the MFF, the exposed subject tends initially to experience a sweet or metallic taste in their mouth and, on occasion, changes in the taste of food or tobacco. Non-specific symptoms may subsequently appear (headache, asthenia, arthralgia, and myalgia). Moreover, there may be a sensation of pharyngeal dryness and irritation, hoarseness and cough. Fever, chills, chest tightness, and dyspnea develop later. Other common symptoms are abdominal pain and nausea, with or without vomiting. Physical examination findings depend on when the patient is evaluated, but, in general, tend to be minimal. In any case, it is very unlikely that complications related to MFF will occur.1,2

The clinical presentation of PFF is more varied,10 but those affected do not experience the metallic taste in the mouth observed MFF. In addition, there is a greater dose-response relationship. Thus, if exposure is more intense, severe acute lung damage can occur, with chemical pneumonitis or non-cardiogenic acute pulmonary edema (APE).2

The diagnosis is based on clinical suspicion, and there is no diagnostic test for MFF or PFF. Clinical laboratory findings are non-specific.1,2 Chest X-ray is usually normal, although the emergence of diffuse pulmonary infiltrates11 and interstitial pattern2 have been described. With regard to lung function, reductions in forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, diffusing capacity of the lung for carbon monoxide, and partial pressure of oxygen may be observed, although they are uncommon and rarely persist after the resolution of the clinical Picture.12

With respect to differential diagnosis, the rapid resolution of symptoms in MFF is a key feature that differentiates this process from infectious syndromes. A differential diagnosis should also be performed with other entities, such as hypersensitivity pneumonitis, organic dust toxic syndrome, and chemical pneumonitis.13

There is no specific treatment for the MFF or PFF.1,2 The best treatment is prevention, which includes various strategies, such as increasing general ventilation, installing combustion gas extractor hoods to reduce concentrations of fumes, and using personal protective equipment for the eyes and skin, as well as respirators delivering positive pressure air.2

Temporary sick leave must continue until the remission of symptoms. Workers can resume welding operations after recovery and return to work, provided that adequate protective measures are taken, nor is it necessary to consider a change of job or a proposal for permanent disability. However, it should be borne in mind that severe episodes that are accompanied by extensive chemical pneumonitis, non-cardiogenic APE or reactive airway dysfunction syndrome can produce permanent functional sequelae that make it necessary to consider permanent disability.2 In this respect, it should be noted that fever caused by metal fumes and other low molecular weight substances is recognized as an occupational disease.14

Finally, our ability to recognize a possible inhalation syndrome depends on two factors: knowledge of its etiology, and the compilation of an appropriate occupational history.15 An early diagnosis can lead to more targeted management and rule out the possibility of a more severe inhalation syndrome.

References
[1]
M.J. Chillón Martin, J. de Miguel Diez, M. Fuentes Alonso.
Fiebres inhalatorias.
Monografías de la Sociedad Madrileña de Neumología y Cirugía Torácica. Enfermedades ocupacionales, pp. 31-41
[2]
L. Carazo Fernández.
Directrices para la decisión clínica en enfermedades profesionales Enfermedades profesionales de naturaleza respiratoria. Fiebre de los metales y de otras sustancias de bajo peso molecular. DDC-RES-03.
Instituto Nacional de Seguridad e Higiene en el Trabajo, (2015),
[3]
M.I. Greenberg, D. Vearrier.
Metal fume fever and polymer fume fever.
Clin Toxicol (Phila), 53 (2015), pp. 195-203
[4]
J.R. Cain, R.M. Fletcher.
Diagnosing metal fume fever—an integrated approach.
Occup Med (Lond), 60 (2010), pp. 398-400
[5]
T. Gordon, J.M. Fine.
Metal fume fever.
Occup Med, 8 (1993), pp. 504-517
[6]
D.J. Shusterman.
Polymer fume fever and other fluorocarbon pyrolysis-related syndromes.
Occup Med, 8 (1993), pp. 519-531
[7]
P. Kaye, H. Young, I. O'Sullivan.
Metal fume fever: a case report and review of the literature.
Emerg Med J, 19 (2002), pp. 268-269
[8]
P. Blanc, H. Wong, M.S. Bernstein, H.A. Boushey.
An experimental human model of metal fume fever.
Ann Intern Med, 114 (1991), pp. 930-936
[9]
C.E. Lewis, G.R. Kerby.
An epidemic of polymer-fume fever.
JAMA, 191 (1965), pp. 375-378
[10]
T. Shimizu, O. Hamada, A. Sasaki, M. Ikeda.
Polymer fume fever.
[11]
B. Ebran, J. Quieffin, G. Beduneau, C.D. Guyonnaud.
Radiological evidence of lung involvement in metal fume fever.
Rev Pneumol Clin, 56 (2000), pp. 361-364
[12]
E.J. Mueller, D.L. Seger.
Metal fume fever—a review.
J Emerg Med, 2 (1985), pp. 271-274
[13]
E. Mañas Baena, E. Pérez Rodríguez, A. Pacheco Galván, J. Gaudó Navarro.
Fiebre por humo de metal en un soldador de profesión.
Rev Patol Respir, 9 (2006), pp. 23-25
[14]
Real Decreto 1299/2006, de 10 de noviembre, por el que se aprueba el cuadro de enfermedades profesionales en el sistema de la Seguridad social y se establecen criterios para su notificación y registro. BOE núm. 302 de 19 de diciembre del 2006.
[15]
A. Wong, S. Greene, J. Robinson.
Metal fume fever—a case review of calls made to the Victorian Poisons Information Centre.
Aust Fam Physician, 41 (2012), pp. 141-143

Please cite this article as: de Miguel Díez J, Cerezo Lajas A, Puente Maestu L. Fiebre por humos, qué debemos distinguir. Arch Bronconeumol. 2019;55:451–452.

Copyright © 2019. SEPAR
Idiomas
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?